Screening Pathways and Practical Research on Primary Care Disease Groups under the DIP Payment
- VernacularTitle:DIP支付方式下基层病种筛选的实践路径与应用研究
- Author:
Xiaolin CAO
1
;
Tiange LIN
;
Mengyun SUI
;
Yazi LI
Author Information
1. 中国医学科学院医学信息研究所 北京 100020
- Publication Type:Journal Article
- Keywords:
Diagnosis-Intervention Packet;
primary care disease group screening;
hierarchical diagnosis
- From:
Chinese Health Economics
2025;44(8):42-44,48
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore screening pathways and practical implementation strategies for primary care disease groups un-der the Diagnosis-Intervention Packet(DIP)payment.Methods:Matching and expert consultation methods were used to select primary care conditions,and experts included DIP National Steering Group experts,DIP experts from a sample municipal health-care security bureau,health policy researchers,coders from a tertiary hospital in Beijing,and big data engineers.Results:The DIP primary disease of"conservative treatment groups"in primary and secondary medical institutions were 104 and 105,repective-ly.The DIP primary disease of"primary can be completed groups"were 74 and 171,respectively.The final number of primary diseases in primary and secondary hospital was determined to be 178 and 276,respectively.Conclusions:The number of primary care disease groups varies from place to place,but it still needs to be dynamically adjusted and optimized in conjunction with big data methods and expert consultation,evaluated and corrected in a timely manner to ensure scientificity and effectiveness.The pri-mary care disease groups implement"same price for the same disease"across different levels of medical institutions,eliminating the differentiation of medical institution grade coefficients to promote hierarchical diagnosis and treatment.Cost-value measurement of disease group,scientific development of payment criteria for disease group,lack of regulatory tools for big data,and high sets of codes are key barriers to primary care implementation.
